Suppositories with dibunol and oil extraction of propolis for treating patients for gynecological inflammatory diseases

FIELD: medicine.

SUBSTANCE: means has dibunol, 15% oil extraction of propolis, gelatin, glycerol and treated water taken in known component proportion.

EFFECT: enhanced effectiveness of treatment; prolonged regenerating and antibacterial action.

2 cl


The present invention relates to medicine, namely to the pharmacy, and concerns the development of medical suppositories containing BHT, and can be used in complex treatment of inflammatory diseases of female sexual sphere (salpingoophoritis, endometritis).

Known drug with antioxidant properties and a wide range of pharmacological activity “10% liniment dibunola” (VFS 42-326-79) under the following proportions of ingredients: BHT 10,0; vegetable oil to 100.0 /1/.

Described drug with reparative action, is the closest analogue of the present invention to the technical essence and the achieved result.

However, the known drug containing BHT and oil-based, has the following disadvantages. therapeutic effect of 10% liniment has prolonged action due to liquid consistency and is mainly used when plugging gynecological patients in the clinic or independently, that is some inconvenience in use.

The objective of the invention is to create a new dosed medications domestic production in the form of suppositories containing BHT and oil extract of propolis with regenery the existing and antibacterial action, with a uniform release, suitable for use by patients on their own, with a pronounced and prolonged action of the drug.

The technical result - the reduction of terms of complex treatment of patients with inflammatory diseases of female reproductive organs through prolonged action, as well as the convenience and hygiene applications.

This technical result is achieved by the fact that the claimed suppositories for the treatment of inflammatory diseases of female sexual sphere contain the active substance BHT, oil extract of propolis, and as suppozitornoj bases contain gelatin, glycerin and purified water in the following ratio, wt.%:

BHT 0,50

Oil extract of propolis 15%0,09

Gelatin 0,37

Glycerin 1,87

Purified water 0,75

All components included in the suppositories allowed for medical use. BHT VFS 42-457-75. Propolis is THE GOST 28886-90. Gelatin medical GF X, p 309. Glycerin FS 42-2202-84. Purified water FS 42-2619-89.

As a result of experimental studies, it was found that the tubes have a high bioavailability and a number of advantages: they have a beautiful appearance, homogeneous, elastic, which is important for vaginal medicines; therapeutic effect on bunola and propolis is manifested through 5 minutes after administration; complete dissolution in 12 minutes. Suppositories are very promising for applications in gynecology. 15% oil extract of propolis promotes better distribution dibunola. Giving the drug form of suppositories provides convenience and hygiene applications, the storage stability. Introduction in the drug of propolis extract in the amount of 3% from suppozitornoj mass in combination with BHT increases antimicrobial activity, tissue regeneration, promotes the expression of analgesic, hemostatic, immunomodulating, reparative effect of the dosage form.

Example 1. Part 1 suppository mass of 3.0 g: BHT 0.5 g 15% oil extract of propolis 0.09 g, gelatin and 0.37 g, glycerin 1,87 g, distilled water of 0.75.

In beaker pre-soaked gelatin in the calculated amount of water (60-90 minutes), melted in a water bath at a temperature of not more than 70°add the glycerin. To remove air without mixing incubated for 30 minutes at a temperature of 45° C. BHT dissolved in the oil extract of propolis and introduced, while stirring continuously with a glass rod in suppozitornyj mass. Metal suppozitornoj form is wiped with a gauze pad moistened with vaseline oil, is cooled in a refrigerator at a temperature of 3-5°during the 5-6 minutes and pour cooked suppozitornyj mass at a temperature of 38-40° C. Form and placed in the fridge for 7-10 minutes, then frozen suppositories are removed. Quality suppositories appreciate the appearance, elasticity, homogeneity.

Received suppositories correct form, homogeneous, elastic and supple.

Example 2.

Part 1 suppository mass of 3.0 g: BHT 0.5 g, 15% oil extract of propolis 0,09 g gelatin 0.5 g glycerol of 1.87 g, distilled water of 0.75.

Make suppositories in a similar way. Received suppositories are solid, ill release the active substances, difficultly soluble, storage crack.

Example 3.

Part 1 suppository mass of 3.0 g: BHT 0.5 g, 15% oil extract of propolis 0.09 g, gelatin and 0.37 g, glycerol 3.0 g, distilled water of 0.75.

Make suppositories in a similar way. Mass is very soft and poorly hardens, removing from suppozitornoj shape is difficult and it is impossible suppositories are torn.

The given examples show that the optimal from the point of view of ease of use, effectiveness of treatment is the composition described in example 1.

Clinical trials have shown that the amount of released drug at a given ratio of components in one suppositories equally in patients studied. This allows the gynecologist, in practical medicine, depending on the shape and ties and diseases to recommend patients required number of suppositories for self-treatment, what makes the claimed suppositories, promising dosage form in practical gynecology. For example, studies have been conducted on the use of suppositories in treatment of gynecological diseases of female genital sphere (salpingoophoritis, endometritis). It is possible to use suppositories sick yourself. After conducting a full-scale clinical trials and the development of methods for quality control of suppositories planned design monograph.

The source of information

1. VFS 42-326-79 “10% liniment dibunola”.

1. The treatment for gynecological inflammatory diseases containing BHT as an active ingredient and a base, characterized in that it further comprises an oil extract of propolis 15%, and as the basis contains gelatin, glycerin and purified water in the following ratio, wt.%:

BHT 0,5

Oil extract of propolis 15%0,09

Gelatin 0,37

Glycerin 1,87

Purified water 0,75

2. The tool according to claim 1, characterized in that the solvent oil extract of propolis contains vegetable oil.


Same patents:

FIELD: organic chemistry.

SUBSTANCE: invention relates to new antibacterial agents. Invention describes cycloalkyl-substituted derivatives of aminomethylpyrrolidine represented by the general formula (I): wherein each among R1 and R2 represents hydrogen atom; n represents a whole number from 1 to 4; Q represents structural moiety represented by the following formula (Ia): wherein R3 represents cyclic alkyl group comprising from 3 to 6 carbon atoms that can be substituted; R4 represents hydrogen atom; R5 represents hydrogen atom or amino-group; X1 represents halogen or hydrogen atom; A1 represents nitrogen atom or structural moiety represented by the formula (II): wherein X2 represents hydrogen, halogen atom or alkyl group comprising from 1 to 6 carbon atoms, or alkoxyl group comprising from 1 to 6 carbon atoms; X2 and R3 can form a ring structure in common with part of the parent skeleton optionally comprising oxygen, nitrogen or sulfur atom as a ring-forming atoms and optionally comprising alkyl group comprising from 1 to 6 carbon atoms as a substitute; Y represents hydrogen atom. Also, invention describes an antibacterial an agent containing compound by cl. 1. Invention provides preparing new compounds eliciting valuable biological properties.

EFFECT: valuable properties of compounds and agent.

15 cl, 1 tbl, 10 ex

FIELD: medicine, antibiotics.

SUBSTANCE: invention relates to cephalosporin antibiotic - cefuroximaxetil that is used in treatment of bacterial infections. Invention proposes a new form of cefuroximaxetil not forming gel in contact with an aqueous solution. New form represents a solid solution of cefuroximaxetil in polymer and/or solid dispersion on adsorbent. New form of cefuroximaxetil can be used for preparing a granulate that can be used in oral pharmaceutical compositions as tablets or powder. Exclusion of gel-formation allows improving solubility of cefuroximaxetil that results to enhancing absorption of cefuroximaxetil in digestive tract.

EFFECT: improved pharmaceutical properties of combinations.

23 cl, 3 dwg, 8 tbl, 19 ex

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention describes 8-cyclo-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0]-nonane-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid of the formula (I):

in crystalline modification D and a medicinal agent based on thereof eliciting effect against pathogenic microorganisms. The prepared crystalline form of compound of the formula (I) shows low hygroscopicity and can be processed to galenic preparations easily and it has the highest filled density and satisfied fluidity.

EFFECT: valuable properties of agent.

4 cl, 7 dwg, 1 ex

FIELD: organic chemistry, medicine pharmacy.

SUBSTANCE: invention describes 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0]-nonane8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid in the crystalline modification C of the formula (I):

and a medicinal agent eliciting effect against pathogenic microorganisms. This crystalline modification of compound of the formula (I) elicits low hygroscopicity, satisfied friability and can be processed easily to galenic preparations.

EFFECT: valuable properties of agent.

4 cl, 7 dwg, 1 tbl, 1 ex

FIELD: organic chemistry, medicine.

SUBSTANCE: invention describes 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0]-nonane-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid of the formula (I):

in the crystalline modification B and a medicinal agent based on thereof that elicits effect against pathogenic microorganisms. Indicated modification of compound of the formula (I) shows stability and insignificant absorption of air moisture ant doesn't convert to another crystalline modification or amorphous form being even in the prolonged storage.

EFFECT: valuable properties of agent.

4 cl, 4 dwg, 6 ex

FIELD: veterinary science.

SUBSTANCE: the suggested preparation for preventing and treating foot rot in animals includes the product of mustard seeds processing - allyl mustard oil and an emulsifier - an aqueous bischofite solution of natural mineral at the following ratio of components, weight%: allyl mustard oil 0.01-1.0, bischofite 2.0-20.0, water - the rest. The suggested composition is highly efficient and provides improved curative effect after 5-10 foot baths in animals.

EFFECT: higher efficiency.

2 ex

FIELD: organic synthesis.

SUBSTANCE: invention provides 1-methylcarbapenam derivatives having general formula I:


in which R1 represents group COOR3, CONR4R5, cyano, CH2OH, or CH2NR7N8, where R3, R4, R5, R7, and R8 are defined in claims; n = 1, 2, or 3; and X represents sulfur or oxygen atom, pharmacologically acceptable ester and salts thereof, and pharmaceutical compositions showing antibacterial activity and containing indicated compounds as active ingredients. Method of prevention and treatment of bacterial infections using claimed compositions is also provided.

EFFECT: increased assortment of antibacterial drugs.

30 cl, 11 tbl, 161 ex

FIELD: medicine, gynecology.

SUBSTANCE: the present innovation deals with isolating erythrocytic mass, then one should introduce a half of daily dosage of prescribed antibiotic into "Hemacon" container with erythrocytic mass at exposure of 20 min in thermostat at 22 C followed by re-infusion for female patient. Therapy course consists of 3-5 seances conducted in a day or two, in intervals between courses a patient is prescribed for antibiotic as intramuscular injections at conventional daily dosage. The method enables to decrease the expenses of medicinal preparation per therapy course and prevent the necessity of operative interferences.

EFFECT: higher efficiency.

3 ex

FIELD: veterinary science.

SUBSTANCE: invention relates to methods for preparing chemotherapeutic preparation comprising biologically active iodine. Method for preparing bismuth iodide sulfamide is carried out by addition of bismuth basic nitrate to potassium iodide an aqueous solution and heating the reaction mass in acid medium up to 75-80oC. Then streptocide is added and heating is continued up to 100-105oC, kept at this temperature up to the melt formation followed by cooling and grinding. Method provides preparing the end product with the content of elemental iodine 10.8-11.0% by the wasteless technology for a single stage.

EFFECT: improved preparing method.

3 ex

Antibacterial gel // 2247555

FIELD: cosmetology.

SUBSTANCE: the present innovation deals with cosmetic preparation for taking care of skin, in particular. The suggested antibacterial gel consists of either hydroxypropylcellulose or hydroxyethylcellulose, propylene glycol or diethylene glycol compound, polyguanidine or its synergistic mixture with quaternary ammonium compound, chitosan, oxyethylated ether of sorbitane, polyvinyl pyrrolidone at molecular weight ranged 10000 - 40000 or copolymer of polyvinylpyrrolidone, trilon-B - sodium salt of ethylene diamintetraacetic acid, perfumery composition, vitamin constituent and water. The present innovation provides increased regenerating formula of skin and its enhanced barrier function, improves homogeneity of the composition mentioned and its stability.

EFFECT: higher efficiency of application.

5 cl, 4 ex, 3 tbl

FIELD: medicine, gynecology, pharmacology, pharmaceutical industry.

SUBSTANCE: invention proposes a preparation that comprises bacterial mass of live microorganisms as an active component, protecting medium and fat base. The preparation comprises lactobacilli as bacterial mass and one or some eubiotic microorganisms taken among the following group: bifidobacteria, streptococci and lactococci taken in the amount per a single dose. Also, the preparation comprises additionally an acceptable sorbent and a biologically active supplement. Also, invention relates to a method for preparing this preparation that involves preparing firstly lactobacilli bacterial mass and one or some genus of eubiotic microorganisms taken among the following group: bifidobacteria, streptococci and lactococci. Then the prepared bacterial mass of microorganisms is immobilized on sorbent used in medicine in its ratio to bacterial mass of microorganisms = (9-1):(1-9) followed by addition of the protecting medium and biologically active supplement to formed mass in the necessary amount. Also, invention describes a method for prophylaxis and treatment of bacterial vaginitis that involves intravaginal administration of the preparation described above in the amount 1-3 doses, 1-3 times per 24 h. The treatment course is prescribed individually. Invention provides expanding assortment of agents used for treatment of bacterial vaginitis. Invention can be used in obstetric-gynecological practice.

EFFECT: improved method for vaginitis treatment, valuable medicinal properties of preparation.

13 cl, 4 tbl, 1 ex

FIELD: pharmaceutical industry.

SUBSTANCE: rectal- and vaginal-administration suppositories contain 1,3-diethylbenzimidazolium triiodide as active principal, polyvinylpyrrolidone as solubilizer and stabilizer, and lipophilic base with specified proportions of components.

EFFECT: extended therapeutical activity and reduced occurrence of side effects.

4 cl, 2 ex

FIELD: chemical and pharmaceutical industry.

SUBSTANCE: the present innovation deals with creating medicinal preparations of plant origin and could be applied for treating functional constipations and affected biorhythm of defecation. It is suggested to apply either dry aqueous or aqueous-alcoholic extract of horse chestnut seeds of Aesculus species to prepare curative-prophylactic preparation in case of constipation and affected biorhythm of defecation. The suggested preparation should be applied in the form of powder, tablets or suppositories. Pharmaceutical composition for preventing and treating constipation and affected biorhythm of defecation contains an active substance out of medicinal plant and a pharmaceutically acceptable filling agent, moreover, this preparation is designed as suppositories and contains either dry aqueous or aqueous-alcoholic extract of horse chestnut seeds of Aesculus species and suppository hydrophobic foundation at certain content of ingredients. Dry aqueous or aqueous-alcoholic extract contains 1-50% active substance as escin. As foundation it could contain either cacao oil or vitepsol. The method for preventing and treating constipations and affected biorhythm of defecation deals with introducing the suggested pharmaceutical composition into patient's anus 5-15 min before planned act of defecation. Application of "Rectum-activ" preparation provides positive result at treating functional psychogenic constipation: in 5-15 min after introducing a suppository into anus pronounced urgency for defecation. In case of course therapy for 4 wk one should observe restoration of natural urgency for intestinal evacuation. Moreover, purgative preparation causes no unfavorable pain feelings.

EFFECT: higher efficiency.

10 cl, 6 ex

The invention relates to medicine and can be used in proctology, urology, obstetrics and gynecology, Pediatrics, gastroenterology, Oncology, therapy, surgery, etc

The invention relates to compositions and methods for the treatment and prevention of such diseases and conditions as graft rejection, surgical adhesions, inflammatory bowel disease, nasal polyps, and includes delivery to the site of inflammation antimicrotubular agent is paclitaxel, or an analogue or derivative
The invention relates to the field of pharmaceutics and can be used in the treatment of prostatitis
The invention relates to the field of pharmaceutical industry and relates to vaginalnyj suppositories for the treatment of imperative incontinence urination

The invention relates to the field of veterinary obstetrics

The invention relates to medicine, in particular to urology, andrology

The invention relates to the field of pharmacology and medicine

FIELD: medicine.

SUBSTANCE: the present innovation deals with medicinal preparation as an ointment for treating skin burns. The suggested preparation contains bee wax, propolis and vegetable oil. Thus, application of initially intact propolis and bee wax in combination with fatty foundation as vegetable oil enables to cheapen and simplify the technique to prepare the preparation, and optimally matched consistence provides prolonged safety of the preparation and accelerates healing of skin burns.

EFFECT: higher efficiency of therapy.

1 cl, 2 ex